Company / Working Capital per Share
Xenon Pharmaceuticals Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$6.55
FY2025
5-year range
$6.55 / $12.49
FY2021-FY2025
Trend
-15.0%
vs FY2024
Sector context
#86 of 210
Health Care
What the data says
At $6.55, Xenon Pharmaceuticals Inc.'s working capital per share ranks #86 of 210 in the Health Care sector. Working Capital per Share has declined for 4 consecutive years, from $12.49 in FY2021 to $6.55 in FY2025.
Based on SEC 10-K filings.
6.55 in FY2025 with a 5-year CAGR of +6.3%.
Declined from $9.23 to $6.55 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -11.8%
- 5-Year CAGR
- +6.3%
- 10-Year CAGR
- -
Sector benchmark
#86 of 210 in Health CareTop 41% of 210This company $6.55 Sector average $146.86
▼
-95.5% below sector average
Key checks
Key Insights
- Xenon Pharmaceuticals Inc.'s working capital per share has declined for 4 consecutive years.
- In FY2025, working capital per share decreased 15.0% year-over-year.
- Ranks #86 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.55 | -15.0% |
| FY2024 | $7.70 | -16.6% |
| FY2023 | $9.23 | -3.2% |
| FY2022 | $9.54 | -23.6% |
| FY2021 | $12.49 | +158.2% |
| FY2020 | $4.83 | +23.6% |
| FY2019 | $3.91 | -39.9% |
| FY2018 | $6.51 | +186.6% |
| FY2017 | $2.27 | -47.4% |
| FY2016 | $4.32 | +5.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026